MSCTR | Cancer Research |Translational Research
Dr. Ravi Sirdeshmukh did his Ph.D. in Biochemistry from the Center for Cellular and Molecular Biology (CCMB), Hyderabad – a premier national laboratory. He also worked as a post-doctoral visiting associate at the Washington University Medical School, St Louis, MO, and a visiting Scientist at the National Institute of Health, USA. He worked at the CCMB for more than 2 decades, was holding the position of Director-Grade Scientist and heading the Proteomics Lab before joining the Institute of Bioinformatics as Distinguished Scientist. He now holds a joint appointment as Principal Advisor, Neuro-oncology Research at MSCTR. His research interests span in the areas of protein and nucleic acid biochemistry and his earlier work included RNA processing, mRNA stability, structure-function relationship of ‘ribonucleases’ and their regulation. More recently his interests have been in the areas of Proteomics of gliomas – a major class of brain tumors and Head & Neck cancers. At the CCMB, he had been the nodal scientist in CSIR network programs in Proteomics and also served as the Consortium Manager in CSIR Proteomics Network for International Collaborations. He is also associated with some of the International research initiatives in Proteomics such as Membrane Proteomics Initiative of AOHUPO and the ongoing Chromosome Centric Human Proteome Project initiated by HUPO. He is an expert reviewer for International Proteomics journals, a member of the Editorial Board of the International Journal of Proteomics and Bioinformatics. Ravi Sirdeshmukh serves on the research advisory panels of several Institutes and Centers in India and that of US Pharmacopeia for protein therapeutics. He is an elected member of the council of Human Proteome Organization (HUPO) and Asian Oceanian HUPO. He is the founder President of the Proteomics Society, India which is strongly dedicated to Proteomics Education and has played an important role in educational activities in proteomics in India through a large number of invited lectures, organization of training workshops, International Proteomics Conferences and Discussions. He has trained and mentored a number of young associates, Ph.D. students and post-doctoral fellows. At MSCTR, he is spearheading translational research programs in brain tumors.
>